Brief: Scinai Reports Nine-Month 2025 Results As CDMO Growth Continues And Nanoabs Pipeline Advances
02/12/2025 13:51
Dec 2 (Reuters) - Scinai Immunotherapeutics Ltd 2F5y.F: SCINAI REPORTS NINE-MONTH 2025 RESULTS AS CDMO GROWTH CONTINUES AND NANOABS PIPELINE ADVANCES Source text: ID:nPnbl5r2fa Further company coverage: [2F5y.F] ((Reuters.Briefs@thomsonreuters.com;))